Science policy weekly roundup: July 27, 2018 ?>

Science policy weekly roundup: July 27, 2018

U.S. Congress set to fund government well before fiscal deadline

In a move surprising veteran federal budget watchers, the U.S. Senate is on track to pass a bill to fund both the military and a large swath of domestic programs, including the National Institutes of Health. Senate leaders are prioritizing the bill, hoping to avert another government shutdown in October, ahead of this year’s November midterm elections. Read more here.


U.S. House committee holds hearing on implementation of 21st Century Cures Act

On Wednesday, the U.S. House subcommittee on health held a hearing to discuss the implementation of the 21st Century Cures Act passed in December 2016. Francis S. Collins, director of the NIH, and Stephanie Devaney, NIH deputy director of the All of Us program, testified on the program’s large-scale health data-collection initiative. Read more here.


The NIH delays implementation of its clinical trials policy

The NIH has delayed implementation of a new clinical trial policy for brain and behavioral researchers. The new policy, made public in January, will categorize basic science studies using humans similarly to clinical studies testing drugs on humans. Many scientists affected by this policy are resisting the change, which is meant to increase transparency and rigor of these studies. Read more here.


Research dollars at less prestigious universities go farther

A recent study by Wayne Wahls of the University of Arkansas for Medical Sciences has shown that federal research dollars go further at less prestigious institutions. While grant applications, success rates and award sizes are larger at prestigious institutions, the number of publications and citation impact per dollar of funding is higher at less prestigious organizations. Read more here. Work by Wahls was previously covered by ASBMB Today.


ICYMI: Listen to the latest episode of “Pipettes and Politics”

In case you missed it, listen to last week’s episode of the American Society of Biochemistry and Molecular Biology’s science policy podcast “Pipettes and Politics.” Mary Woolley, president and chief executive officer of Research!America, joined in to highlight the importance of science advocacy and discuss ways to get involved. Listen to this episode on SoundcloudiTunes or Stitcher.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.